Overview

ASPirin Intervention for the REDuction of Colorectal Cancer Risk

Status:
Active, not recruiting
Trial end date:
2029-07-01
Target enrollment:
Participant gender:
Summary
This research study is investigating the use of aspirin as a potential chemopreventive agent to reduce risk of colorectal cancer
Phase:
N/A
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborator:
National Cancer Institute (NCI)
Treatments:
Aspirin